SCI-FI MILESTONES
Add Sci-Fi Milestones to your phone
Retrospective source review
Earlier records were checked against available source text. Corroborated core results do not establish engineering readiness, exact experiment dates or independent replication. Records needing corrections or further evidence are held in the research archive.
Institute of Zoology, Chinese Academy of Sciences · 5 October 2026
Engineered avian R2 retrotransposons
Demonstrated site-specific DNA integration into human primary cells using an all-RNA-mediated approach, achieving up to 60% integration efficiency.
PASSGenetic engineeringSCIENTIFIC_RESULTconfidence: high
Search window: 2026-09-09 → 2026-10-08Record: 20261008_061407_genetic-engineering.json
Why it matters
This development introduces a powerful, non-CRISPR alternative for genome editing that uses RNA-mediated mechanisms, potentially reducing off-target effects and complexities associated with traditional DNA-cleaving enzymes.
Verified claims
Engineered variants of avian R2 retrotransposons achieved up to 60% site-specific gene integration across human primary cells.
integration_efficiency: 60 percent
Limitations
- Laboratory scale demonstration in human primary cells; does not establish in vivo efficacy or clinical safety.
- The technology focuses on all-RNA-mediated integration; broader applications for diverse cell types or much larger payloads are subject to further optimization.
Sources
Discovery and engineering of avian R2 retrotransposons for all-RNA-mediated targeted DNA integration in human cellsNature Biotechnology · 2026-10-05 · primary